MedTrace Logo

Texting Atopic Dermatitis Patients to Optimize Learning and EASI Scores

NCT02779426 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 84

Last updated 2017-08-22

No results posted yet for this study

Summary

The purpose of this study is to determine if sending text messages with treatment reminders and facts regarding atopic dermatitis (AD) to caretakers of children with AD will have a positive effect on the disease severity.

Conditions

Interventions

BEHAVIORAL

Text messages

Daily text messages with information about atopic dermatitis and treatment reminders.

Sponsors & Collaborators

Principal Investigators

  • Christine Lauren, MD · Columbia University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Max Age
6 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2016-05-31
Primary Completion
2017-06-30
Completion
2017-07-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02779426 on ClinicalTrials.gov